HEALTH EXPERTS reckon that phenylpropanolamine (PPA) is one of the causes of strokes. The public, therefore, can no longer be sold flu medicines containing PPA. This decision by the Food and Medicine Supervisory Board (BPOM) has had a stroke-like effect on the manufacturers of flu medicines.

Last December, the board announced that manufacturers of flu medicines had to reduce the PPA content to a maximum of 15 mg per dose or 60 mg per day. Those